Silverfin false false 28/02/2026 01/03/2025 28/02/2026 Mr. B. Royle 15/02/2024 26 October 2026 The principal activity of the company was that of a holding company. 15491309 2026-02-28 15491309 bus:Director1 2026-02-28 15491309 2025-02-28 15491309 core:CurrentFinancialInstruments 2026-02-28 15491309 core:CurrentFinancialInstruments 2025-02-28 15491309 core:ShareCapital 2026-02-28 15491309 core:ShareCapital 2025-02-28 15491309 core:RetainedEarningsAccumulatedLosses 2026-02-28 15491309 core:RetainedEarningsAccumulatedLosses 2025-02-28 15491309 core:CostValuation 2025-02-28 15491309 core:CostValuation 2026-02-28 15491309 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2026-02-28 15491309 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2025-02-28 15491309 bus:OrdinaryShareClass1 2026-02-28 15491309 2025-03-01 2026-02-28 15491309 bus:FilletedAccounts 2025-03-01 2026-02-28 15491309 bus:SmallEntities 2025-03-01 2026-02-28 15491309 bus:AuditExemptWithAccountantsReport 2025-03-01 2026-02-28 15491309 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 15491309 bus:Director1 2025-03-01 2026-02-28 15491309 2024-02-15 2025-02-28 15491309 bus:OrdinaryShareClass1 2025-03-01 2026-02-28 15491309 bus:OrdinaryShareClass1 2024-02-15 2025-02-28 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15491309 (England and Wales)

ROYLE CARE HOLDINGS LIMITED

Unaudited Financial Statements
For the financial year ended 28 February 2026
Pages for filing with the registrar

ROYLE CARE HOLDINGS LIMITED

Unaudited Financial Statements

For the financial year ended 28 February 2026

Contents

ROYLE CARE HOLDINGS LIMITED

COMPANY INFORMATION

For the financial year ended 28 February 2026
ROYLE CARE HOLDINGS LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 28 February 2026
DIRECTOR Mr. B. Royle
REGISTERED OFFICE The Annex
121 London Street
Reading
RG1 4QA
United Kingdom
COMPANY NUMBER 15491309 (England and Wales)
ACCOUNTANT Verallo
Century House
Wargrave Road
Henley-on-Thames
Oxfordshire
United Kingdom
RG9 2LT
ROYLE CARE HOLDINGS LIMITED

BALANCE SHEET

As at 28 February 2026
ROYLE CARE HOLDINGS LIMITED

BALANCE SHEET (continued)

As at 28 February 2026
Note 28.02.2026 28.02.2025
£ £
Fixed assets
Investments 3 292,220 292,220
292,220 292,220
Current assets
Debtors 4 1 1
1 1
Creditors: amounts falling due within one year 5 ( 292,006) ( 291,785)
Net current liabilities (292,005) (291,784)
Total assets less current liabilities 215 436
Net assets 215 436
Capital and reserves
Called-up share capital 6 10 10
Profit and loss account 205 426
Total shareholder's funds 215 436

For the financial year ending 28 February 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Royle Care Holdings Limited (registered number: 15491309) were approved and authorised for issue by the Director on 26 October 2026. They were signed on its behalf by:

Mr. B. Royle
Director
ROYLE CARE HOLDINGS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 February 2026
ROYLE CARE HOLDINGS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 February 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

Royle Care Holdings Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Annex, 121 London Street, Reading, RG1 4QA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The Company's current liabilities exceed its current assets. The Company is supported through loans from the Parent Company. The director has received assurances that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the Parent Company will continue to support the Company. After making enquiries, the director believes that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Reporting period length

The prior financial statements have been prepared for a period greater than one year to align with group companies. Therefore, the figures are not entirely comparable.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial assets
An asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

For financial assets carried at amortised cost, the amount of impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

Year ended
28.02.2026
Period from
15.02.2024 to
28.02.2025
Number Number
Monthly average number of persons employed by the Company during the year, including the director 0 0

3. Fixed asset investments

Investments in subsidiaries

28.02.2026
£
Cost
At 01 March 2025 292,220
At 28 February 2026 292,220
Carrying value at 28 February 2026 292,220
Carrying value at 28 February 2025 292,220

4. Debtors

28.02.2026 28.02.2025
£ £
Other debtors 1 1

5. Creditors: amounts falling due within one year

28.02.2026 28.02.2025
£ £
Trade creditors 294 0
Amounts owed to own subsidiaries 289,255 155,664
Other creditors 2,457 136,121
292,006 291,785

6. Called-up share capital

28.02.2026 28.02.2025
£ £
Allotted, called-up and fully-paid
10 Oridinary ordinary shares of £ 1.00 each 10 10